Skip to main content
OpenTrials
Completed

NCT Number: NCT02836938

Breath Volatile Organic Compounds Patterns of Lung Transplant Patients With Chronic Lung Allograft Dysfunction

It's the aim of this study to clarify, whether the non-invasive assessment of breath can serve as a novel clinical tool to assist in the diagnosis of CLAD. If different stages of BOS can be discriminated by the level of certain VOCs than there would also be a potential to actually predict the development at an early stage and would enable an earlier intervention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Lung Allograft Dysfunction (CLAD)

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hannover Medical School

Hanover, 30625, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Outpatient bilateral lung transplant recipients including combined transplants

Exclusion criteria

  • Active Smoking Oxygen therapy Infection with multi or pan-resistant bacteria

Treatment and study plan

Collection of exhaled breath volatile organic compounds

Other

Primary outcomes

  1. Concentration of exhaled breath volatile organic compounds

    Time frame: one sample will be collected between 6 month and 20 years after lung transplantation

Sponsors and collaborators

Lead sponsor

Prof. Dr. Jens Hohlfeld

Other

Collaborators

  • Hannover Medical School

Registry information

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Jul 19, 2016
Registry last updated
Feb 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.